These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24205842)

  • 1. Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS.
    Carter MD; Crow BS; Pantazides BG; Watson CM; Thomas JD; Blake TA; Johnson RC
    Anal Chem; 2013 Nov; 85(22):11106-11. PubMed ID: 24205842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
    Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic detection of organophosphorus nerve agent adducts to butyrylcholinesterase in plasma using liquid chromatography-tandem mass spectrometry combined with an improved procainamide-gel separation and pepsin digestion method.
    Liu CC; Liang LH; Yan L; Chen B; Liu XJ; Yang Y; Liu SL; Xi HL
    J Chromatogr A; 2023 May; 1697():463990. PubMed ID: 37075496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-throughput UHPLC-MS/MS method for the quantification of five aged butyrylcholinesterase biomarkers from human exposure to organophosphorus nerve agents.
    Graham LA; Johnson D; Carter MD; Stout EG; Erol HA; Isenberg SL; Mathews TP; Thomas JD; Johnson RC
    Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27572107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS.
    Johnson D; Carter MD; Crow BS; Isenberg SL; Graham LA; Erol HA; Watson CM; Pantazides BG; van der Schans MJ; Langenberg JP; Noort D; Blake TA; Thomas JD; Johnson RC
    J Mass Spectrom; 2015 Apr; 50(4):683-92. PubMed ID: 26149113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum.
    Sporty JL; Lemire SW; Jakubowski EM; Renner JA; Evans RA; Williams RF; Schmidt JG; van der Schans MJ; Noort D; Johnson RC
    Anal Chem; 2010 Aug; 82(15):6593-600. PubMed ID: 20617824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel dual-mode immunomagnetic method for studying reactivation of nerve agent-inhibited butyrylcholinesterase.
    Abney CW; Knaack JL; Ali AA; Johnson RC
    Chem Res Toxicol; 2013 May; 26(5):775-82. PubMed ID: 23656164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-scale purification of butyrylcholinesterase from human plasma and implementation of a μLC-UV/ESI MS/MS method to detect its organophosphorus adducts.
    John H; Breyer F; Schmidt C; Mizaikoff B; Worek F; Thiermann H
    Drug Test Anal; 2015 Oct; 7(10):947-56. PubMed ID: 25828536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput diagnostic method for measuring human exposure to organophosphorus nerve agents.
    Knaack JS; Zhou Y; Abney CW; Jacob JT; Prezioso SM; Hardy K; Lemire SW; Thomas J; Johnson RC
    Anal Chem; 2012 Nov; 84(21):9470-7. PubMed ID: 23083472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
    Tsuge K; Seto Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective screening method for carbamate toxicant exposure based on butyrylcholinesterase adducts in human plasma with ultra-high performance liquid chromatography-tandem mass spectrometry.
    Ren Z; Chen B; Liang D; Liu D; Lei W; Liu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123775. PubMed ID: 37285767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enhanced butyrylcholinesterase method to measure organophosphorus nerve agent exposure in humans.
    Pantazides BG; Watson CM; Carter MD; Crow BS; Perez JW; Blake TA; Thomas JD; Johnson RC
    Anal Bioanal Chem; 2014 Aug; 406(21):5187-94. PubMed ID: 24604326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Confidence Qualitative Identification of Organophosphorus Nerve Agent Adducts to Human Butyrylcholinesterase.
    Mathews TP; Carter MD; Johnson D; Isenberg SL; Graham LA; Thomas JD; Johnson RC
    Anal Chem; 2017 Feb; 89(3):1955-1964. PubMed ID: 28208252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous measurement of tabun, sarin, soman, cyclosarin, VR, VX, and VM adducts to tyrosine in blood products by isotope dilution UHPLC-MS/MS.
    Crow BS; Pantazides BG; Quiñones-González J; Garton JW; Carter MD; Perez JW; Watson CM; Tomcik DJ; Crenshaw MD; Brewer BN; Riches JR; Stubbs SJ; Read RW; Evans RA; Thomas JD; Blake TA; Johnson RC
    Anal Chem; 2014 Oct; 86(20):10397-405. PubMed ID: 25286390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verification of exposure to cholinesterase inhibitors: generic detection of OPCW Schedule 1 nerve agent adducts to human butyrylcholinesterase.
    van der Schans MJ; Fidder A; van Oeveren D; Hulst AG; Noort D
    J Anal Toxicol; 2008; 32(1):125-30. PubMed ID: 18269804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
    Lee JY; Kim C; Lee YH
    J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontargeted High-Resolution Mass Spectrometric Workflow for the Detection of Butyrylcholinesterase-Derived Adducts with Organophosphorus Toxicants and Structural Characterization of Their Phosphyl Moiety after In-Source Fragmentation.
    John H; Dentzel M; Siegert M; Thiermann H
    Anal Chem; 2022 Feb; 94(4):2048-2055. PubMed ID: 35041786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Efficiency of Purification (from Human Plasma) of a Nerve Agent Adduct of Butyrylcholinesterase Between the Affinity Gel Method and Immunomagnetic Separation.
    Lee JY
    J Chromatogr Sci; 2018 Mar; 56(3):248-253. PubMed ID: 29244127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry based proteomic approach for the screening of butyrylcholinesterase adduct formation with organophosphates.
    Dubrovskii Y; Murashko E; Chuprina O; Beltyukov P; Radilov A; Solovyev N; Babakov V
    Talanta; 2019 May; 197():374-382. PubMed ID: 30771950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of immobilized-pepsin microreactors coupled to nano liquid chromatography and tandem mass spectrometry for the quantitative analysis of human butyrylcholinesterase.
    Bonichon M; Combès A; Desoubries C; Bossée A; Pichon V
    J Chromatogr A; 2016 Aug; 1461():84-91. PubMed ID: 27492594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.